AR054377A1 - Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-ciclofenil) (4-piridilmetil) ftalazin -1-il0) micronizado y sus sales - Google Patents
Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-ciclofenil) (4-piridilmetil) ftalazin -1-il0) micronizado y sus salesInfo
- Publication number
- AR054377A1 AR054377A1 ARP060102364A ARP060102364A AR054377A1 AR 054377 A1 AR054377 A1 AR 054377A1 AR P060102364 A ARP060102364 A AR P060102364A AR P060102364 A ARP060102364 A AR P060102364A AR 054377 A1 AR054377 A1 AR 054377A1
- Authority
- AR
- Argentina
- Prior art keywords
- micronized
- immediate release
- salts
- drug load
- high drug
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 239000012729 immediate-release (IR) formulation Substances 0.000 title abstract 2
- 229960002944 cyclofenil Drugs 0.000 title 1
- -1 (4-chlorophenyl) [4- (4-pyridylmethyl) -phthalazin-1-yl] Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000007787 solid Substances 0.000 abstract 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
- 239000007836 KH2PO4 Substances 0.000 abstract 1
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- 239000012738 dissolution medium Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 abstract 1
- 235000019796 monopotassium phosphate Nutrition 0.000 abstract 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Formulaciones farmacéuticas solidas de liberacion inmediata y con una carga de droga elevada que comprenden (4-clorofenil)[4-(4-piridilmetil)-ftalazin-1-ilo] micronizado, así como sus sales aceptables para uso farmacéutico. Reivindicacion 1: Una formulacion farmacéutica solida caracterizada porque comprende: a) al menos 50% en peso, respecto de la formulacion total, de (4-clorofenil)[4-(4-piridilmetil)-ftalazin-1-ilo] micronizado, o una sal de éste aceptable para el uso farmacéutico, y b) al menos un desintegrante basado en carboximetilcelulosa, donde al menos 70% de dicho (4-clorofenil)[4-(4-piridilmetil)-ftalazin-1-ilo], o una sal de éste aceptable para el uso farmacéutico, se disuelve a partir de dicha formulacion farmacéutica solida en 30 minutos, lo que se determina con el método con paletas USP 28, usando amortiguador de KH2PO4/HCl 0,05 M ajustado a pH 3,0 a 37 degree C como medio de disolucion, y 50 rpm como velocidad de agitacion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05090167A EP1731154A1 (en) | 2005-06-07 | 2005-06-07 | Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)|4-(4-pyridylmethyl)pht halazin-1-yl| and salts thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR054377A1 true AR054377A1 (es) | 2007-06-20 |
Family
ID=34938468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060102364A AR054377A1 (es) | 2005-06-07 | 2006-06-07 | Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-ciclofenil) (4-piridilmetil) ftalazin -1-il0) micronizado y sus sales |
Country Status (22)
| Country | Link |
|---|---|
| EP (2) | EP1731154A1 (es) |
| JP (1) | JP2008542421A (es) |
| KR (1) | KR20080017443A (es) |
| CN (1) | CN101242841A (es) |
| AR (1) | AR054377A1 (es) |
| AU (1) | AU2006256853A1 (es) |
| BR (1) | BRPI0611818A2 (es) |
| CA (1) | CA2610977A1 (es) |
| CR (1) | CR9577A (es) |
| CU (1) | CU20070272A7 (es) |
| DO (1) | DOP2006000128A (es) |
| EC (1) | ECSP078037A (es) |
| GT (1) | GT200600243A (es) |
| IL (1) | IL187906A0 (es) |
| MX (1) | MX2007015495A (es) |
| NO (1) | NO20080066L (es) |
| PE (1) | PE20070012A1 (es) |
| RU (1) | RU2007147953A (es) |
| TW (1) | TW200716114A (es) |
| UY (1) | UY29585A1 (es) |
| WO (1) | WO2006131394A1 (es) |
| ZA (1) | ZA200800113B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1958615A1 (en) * | 2007-02-13 | 2008-08-20 | Bayer Schering Pharma Aktiengesellschaft | Solid pharmaceutical formulations of a homogeneous dispersion of active principles having pH-dependent solubility |
| EP1958616A1 (en) * | 2007-02-13 | 2008-08-20 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof |
| AR101476A1 (es) | 2014-08-07 | 2016-12-21 | Acerta Pharma Bv | Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO4950519A1 (es) | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
| US6482802B1 (en) | 1998-05-11 | 2002-11-19 | Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
-
2005
- 2005-06-07 EP EP05090167A patent/EP1731154A1/en not_active Withdrawn
-
2006
- 2006-06-06 AU AU2006256853A patent/AU2006256853A1/en not_active Abandoned
- 2006-06-06 PE PE2006000620A patent/PE20070012A1/es not_active Application Discontinuation
- 2006-06-06 CU CU20100122A patent/CU20070272A7/es unknown
- 2006-06-06 BR BRPI0611818-6A patent/BRPI0611818A2/pt not_active IP Right Cessation
- 2006-06-06 MX MX2007015495A patent/MX2007015495A/es not_active Application Discontinuation
- 2006-06-06 KR KR1020087000234A patent/KR20080017443A/ko not_active Withdrawn
- 2006-06-06 CN CNA2006800294846A patent/CN101242841A/zh active Pending
- 2006-06-06 GT GT200600243A patent/GT200600243A/es unknown
- 2006-06-06 RU RU2007147953/15A patent/RU2007147953A/ru not_active Application Discontinuation
- 2006-06-06 JP JP2008515152A patent/JP2008542421A/ja active Pending
- 2006-06-06 EP EP06762011A patent/EP1888073A1/en not_active Withdrawn
- 2006-06-06 TW TW095120061A patent/TW200716114A/zh unknown
- 2006-06-06 CA CA002610977A patent/CA2610977A1/en not_active Abandoned
- 2006-06-06 WO PCT/EP2006/005601 patent/WO2006131394A1/en not_active Ceased
- 2006-06-07 DO DO2006000128A patent/DOP2006000128A/es unknown
- 2006-06-07 UY UY29585A patent/UY29585A1/es not_active Application Discontinuation
- 2006-06-07 AR ARP060102364A patent/AR054377A1/es unknown
-
2007
- 2007-12-05 IL IL187906A patent/IL187906A0/en unknown
- 2007-12-07 CR CR9577A patent/CR9577A/es not_active Application Discontinuation
- 2007-12-19 EC EC2007008037A patent/ECSP078037A/es unknown
-
2008
- 2008-01-04 NO NO20080066A patent/NO20080066L/no not_active Application Discontinuation
- 2008-01-04 ZA ZA200800113A patent/ZA200800113B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT200600243A (es) | 2007-07-16 |
| ZA200800113B (en) | 2009-07-29 |
| WO2006131394A1 (en) | 2006-12-14 |
| IL187906A0 (en) | 2008-03-20 |
| RU2007147953A (ru) | 2009-07-20 |
| MX2007015495A (es) | 2008-02-22 |
| JP2008542421A (ja) | 2008-11-27 |
| NO20080066L (no) | 2008-03-06 |
| KR20080017443A (ko) | 2008-02-26 |
| CA2610977A1 (en) | 2006-12-14 |
| CN101242841A (zh) | 2008-08-13 |
| TW200716114A (en) | 2007-05-01 |
| CR9577A (es) | 2008-03-06 |
| AU2006256853A1 (en) | 2006-12-14 |
| ECSP078037A (es) | 2008-01-23 |
| BRPI0611818A2 (pt) | 2010-09-28 |
| EP1731154A1 (en) | 2006-12-13 |
| EP1888073A1 (en) | 2008-02-20 |
| UY29585A1 (es) | 2007-01-31 |
| DOP2006000128A (es) | 2006-12-15 |
| CU20070272A7 (es) | 2010-09-30 |
| PE20070012A1 (es) | 2007-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0615292A8 (pt) | composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada | |
| CY1121782T1 (el) | Διαδικασια για ξηρανση της bibw2992, tων αλατων αυτης και στερεων φαρμακευτικων σκευασματων που περιλαμβανουν αυτο το δραστικο συστατικο | |
| ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
| HRP20090340T1 (hr) | Derivati 5-fenil-4-metil-tiazol-2-il-amina kao inhibitori enzima fosfatidilinozitol 3-kinaza (pi3) za liječenje upalnih bolesti dišnih puteva | |
| AR084101A2 (es) | Comprimido de carga de droga alta y proceso para su preparacion | |
| NO20083027L (no) | Kontrollert frigivelses-fastformpreparat | |
| TW200744677A (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
| CY1110906T1 (el) | Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης | |
| NO20081889L (no) | Fast vaksine formulering | |
| ECSP11011500A (es) | DERIVADOS DE 1H-IMIDAZO-[4,5-c]-QUINOLINONA | |
| MA30725B1 (fr) | Administration d'inhibiteurs de la dipeptidyl peptidase | |
| AR078846A1 (es) | Composicion para el tratamiento de la enfermedad de alzheimer | |
| PE20100252A1 (es) | Nuevas formulaciones farmaceuticas solidas que comprenden dimaleato de 4-[(3-cloro-4-fluorofenil) amino]-6-{[4-(n,n-dimetilamino)-1-oxo-2-buten-1-il] amino}-7-((s)-tetrahidrofuran-3-iloxi)-quinazolina | |
| AR063538A1 (es) | Tratamiento de la enfermedad de parkinson | |
| WO2008060934A3 (en) | Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration | |
| ATE485049T1 (de) | Physiologisch aktive zusammensetzung gegen diabetes | |
| MA29922B1 (fr) | NOUVEAUX DERIVES DE BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE CMet | |
| AR054377A1 (es) | Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-ciclofenil) (4-piridilmetil) ftalazin -1-il0) micronizado y sus sales | |
| AR071706A1 (es) | Una formulacion farmaceutica de cilostazol solida de liberacion sostenida y metodo de preparacion. | |
| EA201070806A1 (ru) | Состав медленного высвобождения на основе ассоциации гликогена и альгината | |
| EA201000701A1 (ru) | 4-[4-(2-адамантилкарбамоил)-5-трет-бутилпиразол-1-ил]бензойная кислота-465 | |
| AR053889A1 (es) | Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-ciclofenil) [4-(4-piridilmetil) ftalazin-1-llo] no micronizado y sus sales | |
| NO20090579L (no) | Preparater med kontrollerte farmakokinetikker | |
| DK1653923T3 (da) | Oral afleveringssystem omfattende en bivæsket skum | |
| AR062674A1 (es) | Formulacion acuosa que comprende un agente antitumoral |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |